Hims & Hers CFO Sells $1.1M in Stock at $47 Per Share

Hims & Hers Health (HIMS) Chief Financial Officer Oluyemi Okupe executed a planned sale of 23,107 shares of Class A Common Stock on June 23, 2025, at an average weighted price of $47.2483 per share (range: $47.15 - $47.43).

Rhea-AI Filing Summary

Hims & Hers Health (HIMS) Chief Financial Officer Oluyemi Okupe executed a planned sale of 23,107 shares of Class A Common Stock on June 23, 2025, at an average weighted price of $47.2483 per share (range: $47.15 - $47.43).

Following the transaction, Okupe's holdings include:

• 63,222 shares held directly
• 70,575 shares held indirectly through the Oluyemi Okupe Separate Property Trust

The sale was conducted under a Rule 10b5-1 trading plan established on May 31, 2024, demonstrating pre-planned, compliant insider trading activity. This transaction represents a partial reduction of the CFO's direct holdings while maintaining significant equity stake in the company through both direct and trust ownership.

Insider Trade Summary

Net Seller: 23,107 shares

Net Sell 2 txns

Insider Okupe Oluyemi

Role Chief Financial Officer

Sold 23,107 shs ($1.09M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	23,107	$47.2483	$1.09M
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 63,222 shares (Direct); Class A Common Stock — 70,575 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)

Footnotes (2)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.
2. F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $47.15 - $47.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS shares did CFO Oluyemi Okupe sell on June 23, 2025?

CFO Oluyemi Okupe sold 23,107 shares of HIMS Class A Common Stock on June 23, 2025 at an average weighted price of $47.2483 per share.

What is the total HIMS stock ownership of CFO Oluyemi Okupe after the June 2025 transaction?

After the transaction, CFO Oluyemi Okupe owned a total of 133,797 shares of HIMS, consisting of 63,222 shares held directly and 70,575 shares held indirectly through the Oluyemi Okupe Separate Property Trust dated 9-1-2021.

Was HIMS CFO Okupe's stock sale part of a pre-planned trading arrangement?

Yes, the sales were executed pursuant to a Rule 10b5-1 trading plan that was adopted by CFO Okupe on May 31, 2024, approximately one year before the transaction.

What was the price range of HIMS shares sold by CFO Okupe in the June 2025 transaction?

The HIMS shares were sold at varying prices ranging from $47.15 to $47.43 per share, with a weighted average price of $47.2483.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2025 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/23/2025		S(1)		23,107	D	$47.2483(2)	63,222	D
Class A Common Stock								70,575	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $47.15 - $47.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.